
About Bandaram Pharma Packtech Limited
Data last updated:
Bandaram Pharma Packtech Limited is a public limited company based in Bangalore, Karnataka, India. It operates in the paper and packaging products segment of the manufacturing sector. It was incorporated on 05 August 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN L93090KA1993PLC159827. Its GSTIN is 29AAACS0289E1ZD (Karnataka). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 524602.
The company has an authorised share capital of ₹19 Cr and a paid-up capital of ₹17.97 Cr. It is led by directors including Deepak Bandaram (Managing Director) and Bhandaram Sathyavathi.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 601 5th Floor Oxford Towers Opp To Leela Palace Hotel Old Airport Road Kodihalli, Bangalore, Karnataka, India – 560008.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹62.92 Cr, a growth of 70.2% compared to the previous year. For the same year it recorded a net profit of ₹45 Lakh (net margin 0.7%) and EBITDA of ₹2.9 Cr (EBITDA margin 4.6%). The net worth stands at ₹26.78 Cr (up 111.7% YoY). Total assets are valued at ₹55.31 Cr (up 67.7% YoY).
The company is associated with 2 brands: Shiva Medicare and Bandaram Pharma Packtech. As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹18.42 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 1 deal on record (1 acquisition); the latest was in March 2016.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shivamedicare.com.
Company details
CIN history
Bandaram Pharma Packtech has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L93090KA1993PLC159827, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L93090KA1993PLC159827 | Current |
| L93090TG1993PLC088165 | Previous |
| L93090DL1993PLC186295 | Previous |
| L93090TN1993PLC025563 | Previous |
| L93090AP1993PLC088165 | Previous |
Contact details
Bandaram Pharma Packtech Limited's registered office is in Bangalore, Karnataka. Its website is shivamedicare.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address601 5th Floor Oxford Towers Opp To Leela Palace Hotel Old Airport Road Kodihalli, Bangalore, Karnataka, India – 560008
- IndustryManufacturing, Paper & Packaging Products
To see the full contact details of Bandaram Pharma Packtech Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Bandaram Pharma Packtech operates two associated brands: Shiva Medicare and Bandaram Pharma Packtech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of auto retractable safety syringe | shivamedicare.com | |
| Pharmaceutical packaging solutions are provided by Bandaram Pharma Packtech. | bandaram.com |
Financials of Bandaram Pharma Packtech Limited
FY 2025-26 filings availableBandaram Pharma Packtech Limited reported revenue of ₹62.92 Cr (up 70.2% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 62.92 | 36.96 | 34.08 | 18.73 |
| Revenue growth | +70.2% | +8.5% | +82.0% | - |
| EBITDA | 2.90 | 2.81 | 2.82 | 1.15 |
| EBITDA margin | +4.6% | +7.6% | +8.3% | +6.1% |
| Profit before tax | 0.44 | 1.30 | 1.19 | 0.32 |
| Net profit | 0.45 | 0.98 | 0.95 | 0.13 |
| Net profit margin | +0.7% | +2.7% | +2.8% | +0.7% |
| EPS (₹) | 0.25 | 0.83 | 0.79 | 0.47 |
| Balance sheet | ||||
| Total assets | 55.31 | 32.98 | 27.27 | 19.34 |
| Net worth | 26.78 | 12.65 | 12.28 | 3.08 |
| Total debt | 23.95 | 17.15 | 12.20 | 14.20 |
| Cash & bank | 0.72 | 0.12 | 0.04 | 0.16 |
| Net working capital | 36.56 | 25.02 | 21.35 | 14.27 |
| Cash flow | ||||
| Cash from operations | (4.92) | (4.93) | (4.13) | (1.10) |
| Cash from investing | 0.00 | (0.08) | (1.58) | (5.30) |
| Cash from financing | 5.53 | 5.09 | 5.59 | 4.47 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 21.45 | 23.95 | 26.26 | 14.84 | 13.72 | 8.10 | 8.49 | 10.00 |
| Revenue growth (YoY) | +56.3% | +195.7% | +209.3% | +48.4% | +93.0% | -28.8% | - | - |
| Other income | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.09 | 0.00 |
| EBITDA | 1.16 | 1.54 | 0.82 | 1.00 | 0.45 | 0.63 | 0.54 | 0.66 |
| EBITDA margin | +5.4% | +6.4% | +3.1% | +6.7% | +3.3% | +7.8% | +6.4% | +6.6% |
| Depreciation | 0.25 | 0.20 | 0.25 | 0.14 | 0.14 | 0.13 | 0.53 | 0.15 |
| Interest | 0.48 | 0.42 | 0.46 | 0.33 | 0.25 | 0.46 | (0.10) | 0.24 |
| Profit before tax | 0.43 | 0.92 | 0.12 | 0.53 | 0.07 | 0.04 | 0.20 | 0.27 |
| Tax | 0.24 | 0.24 | 0.03 | 0.18 | 0.02 | 0.01 | 0.05 | 0.28 |
| Net profit | 0.19 | 0.68 | 0.09 | 0.35 | 0.05 | 0.03 | 0.15 | (0.01) |
| EPS (₹) | (0.12) | 0.11 | 0.05 | 0.11 | 0.03 | 0.02 | 0.13 | (0.01) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2017-18 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 10.96 | 12.23 | 14.84 | 10.09 | 0.00 | 0.00 | 0.00 |
| Revenue growth | -10.4% | -17.6% | +47.1% | - | - | - | - |
| EBITDA | (1.17) | 0.09 | 0.16 | 0.27 | (0.01) | (0.01) | (1.12) |
| EBITDA margin | -10.7% | +0.7% | +1.1% | +2.7% | - | - | - |
| Profit before tax | (1.16) | 0.17 | 0.17 | 0.27 | (0.01) | (0.03) | (1.16) |
| Net profit | (1.16) | 0.12 | 0.13 | 0.20 | (0.01) | (0.03) | (1.16) |
| Net profit margin | -10.6% | +1.0% | +0.9% | +2.0% | - | - | - |
| EPS (₹) | (0.64) | 0.12 | 0.11 | 0.68 | (0.03) | (0.14) | 0.00 |
| Balance sheet | |||||||
| Total assets | 27.40 | 15.59 | 12.22 | 7.48 | 2.99 | 0.10 | 0.39 |
| Net worth | 22.88 | 12.10 | 12.20 | 3.07 | 2.99 | (2.32) | (1.78) |
| Total debt | 4.51 | 3.49 | 0.02 | 4.41 | 0.00 | 1.45 | 1.20 |
| Cash & bank | 0.26 | 0.02 | 0.04 | 0.09 | 2.08 | 0.00 | 0.00 |
| Net working capital | 5.50 | 6.49 | 8.30 | 4.95 | 2.99 | (0.39) | (0.18) |
| Cash flow | |||||||
| Cash from operations | 1.21 | (3.25) | (3.26) | (3.87) | 2.92 | 0.00 | (0.98) |
| Cash from investing | (2.00) | 0.00 | (1.40) | (2.53) | (1.55) | 0.00 | 0.42 |
| Cash from financing | 1.03 | 3.23 | 4.61 | 4.40 | 0.72 | 0.00 | 0.00 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.37 | 2.99 | 8.20 | 1.68 | 0.33 | 0.76 | 3.71 | 2.63 |
| Revenue growth (YoY) | +618.2% | +293.4% | +121.0% | -36.1% | -89.6% | -72.1% | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.09 | 0.00 |
| Total expenses | 2.78 | 3.34 | 8.53 | 1.89 | 0.68 | 1.03 | 3.75 | 2.58 |
| EBITDA | (0.41) | (0.35) | (0.33) | (0.21) | (0.35) | (0.27) | (0.04) | 0.05 |
| EBITDA margin | -17.3% | -11.7% | -4.0% | -12.5% | -106.1% | -35.5% | -1.1% | +1.9% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.41) | (0.35) | (0.33) | (0.21) | (0.34) | (0.27) | 0.05 | 0.05 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 21.45 | 23.95 | 26.26 | 14.84 | 13.72 | 8.10 | 8.49 | 10.00 |
| Revenue growth (YoY) | +56.3% | +195.7% | +209.3% | +48.4% | +93.0% | -28.8% | - | - |
| Other income | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.09 | 0.00 |
| EBITDA | 1.16 | 1.54 | 0.82 | 1.00 | 0.45 | 0.63 | 0.54 | 0.66 |
| EBITDA margin | +5.4% | +6.4% | +3.1% | +6.7% | +3.3% | +7.8% | +6.4% | +6.6% |
| Depreciation | 0.25 | 0.20 | 0.25 | 0.14 | 0.14 | 0.13 | 0.53 | 0.15 |
| Interest | 0.48 | 0.42 | 0.46 | 0.33 | 0.25 | 0.46 | (0.10) | 0.24 |
| Profit before tax | 0.43 | 0.92 | 0.12 | 0.53 | 0.07 | 0.04 | 0.20 | 0.27 |
| Tax | 0.24 | 0.24 | 0.03 | 0.18 | 0.02 | 0.01 | 0.05 | 0.28 |
| Net profit | 0.19 | 0.68 | 0.09 | 0.35 | 0.05 | 0.03 | 0.15 | (0.01) |
| EPS (₹) | (0.12) | 0.11 | 0.05 | 0.11 | 0.03 | 0.02 | 0.13 | (0.01) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Revenue | 62.92 | 36.96 | 34.08 | 18.73 |
| Revenue growth | +70.2% | +8.5% | +82.0% | - |
| Other income | 0.02 | 0.09 | 0.03 | 0.19 |
| Total expenses | 60.02 | 34.15 | 31.26 | 17.58 |
| Employee cost | 0.00 | 2.96 | 2.33 | 0.64 |
| EBITDA | 2.90 | 2.81 | 2.82 | 1.15 |
| EBITDA margin | +4.6% | +7.6% | +8.3% | +6.1% |
| Depreciation | 0.97 | 0.61 | 0.73 | 0.59 |
| Interest | 1.51 | 0.99 | 0.93 | 0.43 |
| Profit before tax | 0.44 | 1.30 | 1.19 | 0.32 |
| Tax | (0.01) | 0.32 | 0.24 | 0.07 |
| Net profit | 0.45 | 0.98 | 0.95 | 0.13 |
| Net profit margin | +0.7% | +2.7% | +2.8% | +0.7% |
| EPS (₹) | 0.25 | 0.83 | 0.79 | 0.47 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Equity & liabilities | ||||
| Share capital | 17.97 | 12.00 | 12.00 | 3.00 |
| Reserves & surplus | 8.81 | 0.65 | 0.28 | 0.08 |
| Shareholders' funds (net worth) | 26.78 | 12.65 | 12.28 | 3.08 |
| Minority interest | 4.58 | 3.17 | 2.79 | 2.05 |
| Secured loans | 14.92 | 10.52 | 1.78 | 1.97 |
| Unsecured loans | 9.03 | 6.63 | 10.42 | 12.23 |
| Total debt | 23.95 | 17.15 | 12.20 | 14.20 |
| Total liabilities | 55.31 | 32.98 | 27.27 | 19.34 |
| Assets | ||||
| Gross block | 15.22 | 3.95 | 5.91 | 5.03 |
| Net block | 15.22 | 3.95 | 4.48 | 5.03 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 1.40 | 1.40 | 0.00 |
| Inventories | 12.94 | 8.51 | 6.47 | 2.71 |
| Sundry debtors | 31.35 | 18.76 | 14.52 | 6.62 |
| Cash & bank balances | 0.72 | 0.12 | 0.04 | 0.16 |
| Loans & advances | 11.98 | 3.50 | 5.03 | 5.57 |
| Total current assets | 56.99 | 30.89 | 26.06 | 15.06 |
| Total current liabilities | 20.43 | 5.87 | 4.71 | 0.79 |
| Net working capital | 36.56 | 25.02 | 21.35 | 14.27 |
| Total assets | 55.31 | 32.98 | 27.27 | 19.34 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Opening cash | 0.12 | 0.04 | 0.16 | 2.09 |
| Net cash from operating activities | (4.92) | (4.93) | (4.13) | (1.10) |
| Net cash from investing activities | 0.00 | (0.08) | (1.58) | (5.30) |
| Net cash from financing activities | 5.53 | 5.09 | 5.59 | 4.47 |
| Net change in cash | 0.60 | 0.08 | (0.11) | (1.93) |
| Closing cash | 0.72 | 0.12 | 0.04 | 0.16 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Growth | ||||
| Sales growth | +70.2% | +8.5% | +82.0% | - |
| EBITDA growth | +3.2% | -0.4% | +145.2% | - |
| PBT growth | -66.2% | +9.2% | +271.9% | +9997.0% |
| Net income growth | -54.1% | +3.2% | +630.8% | - |
| Revenue CAGR (3Y) | +49.8% | - | - | - |
| EBITDA CAGR (3Y) | +36.1% | - | - | - |
| Profitability & leverage | ||||
| Net income margin | +0.5% | +2.7% | +2.8% | +1.3% |
| Return on capital employed | +4.8% | +8.5% | +10.2% | +4.4% |
| Return on net worth | +1.4% | +7.9% | +12.4% | +8.4% |
| Debt / equity | 1.04 | 1.18 | 1.72 | 4.61 |
| Long-term debt / equity | 0.48 | 0.55 | 0.80 | 2.48 |
| Interest cover | 78.24 | 45.00 | 44.50 | 76.79 |
| Efficiency & per share | ||||
| Fixed asset turnover | 6.56 | 7.50 | 6.23 | 3.72 |
| Inventory turnover | 5.87 | 4.93 | 7.42 | 6.91 |
| Debtors turnover | 2.51 | 2.22 | 3.22 | 2.83 |
| EPS (₹) | 0.16 | 0.83 | 0.79 | 0.47 |
| Dividend per share (₹) | 0.00 | 0.10 | 0.10 | 0.10 |
| Book value per share (₹) | 14.90 | 10.54 | 10.23 | 10.28 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.37 | 2.99 | 8.20 | 1.68 | 0.33 | 0.76 | 3.71 | 2.63 |
| Revenue growth (YoY) | +618.2% | +293.4% | +121.0% | -36.1% | -89.6% | -72.1% | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.09 | 0.00 |
| Total expenses | 2.78 | 3.34 | 8.53 | 1.89 | 0.68 | 1.03 | 3.75 | 2.58 |
| EBITDA | (0.41) | (0.35) | (0.33) | (0.21) | (0.35) | (0.27) | (0.04) | 0.05 |
| EBITDA margin | -17.3% | -11.7% | -4.0% | -12.5% | -106.1% | -35.5% | -1.1% | +1.9% |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.41) | (0.35) | (0.33) | (0.21) | (0.34) | (0.27) | 0.05 | 0.05 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2017-18 |
|---|---|---|---|---|---|---|---|
| Revenue | 10.96 | 12.23 | 14.84 | 10.09 | 0.00 | 0.00 | 0.00 |
| Revenue growth | -10.4% | -17.6% | +47.1% | - | - | - | - |
| Other income | 0.01 | 0.09 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total expenses | 12.13 | 12.14 | 14.68 | 9.82 | 0.01 | 0.01 | 1.12 |
| Employee cost | 0.00 | 1.10 | 1.14 | 0.08 | 0.00 | 0.00 | 0.37 |
| EBITDA | (1.17) | 0.09 | 0.16 | 0.27 | (0.01) | (0.01) | (1.12) |
| EBITDA margin | -10.7% | +0.7% | +1.1% | +2.7% | - | - | - |
| Depreciation | 0.00 | 0.01 | 0.02 | 0.00 | 0.00 | 0.02 | 0.03 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Profit before tax | (1.16) | 0.17 | 0.17 | 0.27 | (0.01) | (0.03) | (1.16) |
| Tax | 0.00 | 0.05 | 0.04 | 0.07 | 0.00 | 0.00 | 0.00 |
| Net profit | (1.16) | 0.12 | 0.13 | 0.20 | (0.01) | (0.03) | (1.16) |
| Net profit margin | -10.6% | +1.0% | +0.9% | +2.0% | - | - | - |
| EPS (₹) | (0.64) | 0.12 | 0.11 | 0.68 | (0.03) | (0.14) | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2017-18 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 17.97 | 12.00 | 12.00 | 3.00 | 3.00 | 2.28 | 2.28 |
| Reserves & surplus | 4.91 | 0.10 | 0.20 | 0.07 | (0.01) | (4.60) | (4.06) |
| Shareholders' funds (net worth) | 22.88 | 12.10 | 12.20 | 3.07 | 2.99 | (2.32) | (1.78) |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 4.51 | 3.49 | 0.02 | 4.41 | 0.00 | 1.45 | 1.20 |
| Total debt | 4.51 | 3.49 | 0.02 | 4.41 | 0.00 | 1.45 | 1.20 |
| Total liabilities | 27.40 | 15.59 | 12.22 | 7.48 | 2.99 | 0.10 | 0.39 |
| Assets | |||||||
| Gross block | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.11 | 0.21 |
| Net block | 0.01 | 0.01 | 0.01 | 0.03 | 0.00 | 0.11 | 0.18 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 17.85 | 3.91 | 3.91 | 2.51 | 0.00 | 0.00 | 0.00 |
| Inventories | 2.08 | 1.64 | 2.16 | 0.55 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 10.67 | 6.62 | 2.40 | 2.69 | 0.00 | 0.00 | 0.00 |
| Cash & bank balances | 0.26 | 0.02 | 0.04 | 0.09 | 2.08 | 0.00 | 0.00 |
| Loans & advances | 1.70 | 1.84 | 4.83 | 2.41 | 0.92 | 0.77 | 0.77 |
| Total current assets | 14.71 | 10.12 | 9.43 | 5.74 | 3.00 | 0.77 | 0.77 |
| Total current liabilities | 9.21 | 3.63 | 1.13 | 0.79 | 0.01 | 1.16 | 0.95 |
| Net working capital | 5.50 | 6.49 | 8.30 | 4.95 | 2.99 | (0.39) | (0.18) |
| Total assets | 27.40 | 15.59 | 12.22 | 7.48 | 2.99 | 0.10 | 0.39 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2017-18 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.02 | 0.04 | 0.09 | 2.08 | 0.00 | 0.00 | 0.57 |
| Net cash from operating activities | 1.21 | (3.25) | (3.26) | (3.87) | 2.92 | 0.00 | (0.98) |
| Net cash from investing activities | (2.00) | 0.00 | (1.40) | (2.53) | (1.55) | 0.00 | 0.42 |
| Net cash from financing activities | 1.03 | 3.23 | 4.61 | 4.40 | 0.72 | 0.00 | 0.00 |
| Net change in cash | 0.24 | (0.02) | (0.04) | (2.00) | 2.08 | 0.00 | (0.56) |
| Closing cash | 0.26 | 0.02 | 0.04 | 0.09 | 2.08 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2017-18 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -10.4% | -17.6% | +47.1% | - | - | - | - |
| EBITDA growth | -1400.0% | -43.8% | -40.7% | +2800.0% | 0.0% | - | - |
| PBT growth | - | 0.0% | -37.0% | +9998.0% | +66.7% | +97.4% | -6.4% |
| Net income growth | -1066.7% | -7.7% | -35.0% | +2100.0% | +66.7% | - | - |
| Revenue CAGR (3Y) | +2.8% | - | - | - | - | - | - |
| EBITDA CAGR (3Y) | - | - | - | - | -79.1% | -41.5% | +382.0% |
| Profitability & leverage | |||||||
| Net income margin | -10.6% | +1.0% | +0.9% | +2.0% | - | - | - |
| Return on capital employed | 0.0% | +1.4% | +1.7% | +5.2% | 0.0% | 0.0% | 0.0% |
| Return on net worth | 0.0% | +1.2% | +1.7% | +6.6% | 0.0% | 0.0% | 0.0% |
| Debt / equity | 0.23 | 0.14 | 0.29 | 0.73 | 2.17 | 0.00 | 0.00 |
| Long-term debt / equity | 0.23 | 0.14 | 0.29 | 0.73 | 2.17 | 0.00 | 0.00 |
| Interest cover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.87 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 365.33 | 407.67 | 494.67 | 672.67 | 0.00 | 0.00 | 0.00 |
| Inventory turnover | 5.89 | 6.44 | 10.95 | 36.69 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 1.27 | 2.71 | 5.83 | 7.50 | 0.00 | 0.00 | 0.00 |
| EPS (₹) | (0.65) | 0.12 | 0.11 | 0.68 | (0.03) | (0.14) | 0.00 |
| Dividend per share (₹) | 0.00 | 0.10 | 0.10 | 0.10 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 12.73 | 10.09 | 10.17 | 10.25 | 9.97 | (10.18) | (7.82) |
To see the full year-wise statements and ratios of Bandaram Pharma Packtech Limited, buy the company report.
Board of directors of Bandaram Pharma Packtech Limited
Bandaram Pharma Packtech has 7 current directors and 26 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhandaram Sathyavathi | Director | 07 Mar 2022 | 4 Years 8 Months | Current |
| Bhandaram Premsai Reddy Also directs: BJN Healthcare Services Private Limited | Director | 07 Mar 2022 | 4 Years 8 Months | Current |
| Suryaprakasa Rao Bommisetti Also directs: Jeevan Scientific Technology Limited, Samsrita Labs Limited | Director | 07 Mar 2022 | 4 Years 8 Months | Current |
| Deepak Bandaram Also directs: VSR Paper and Packaging Limited, RCL Paper and Packagings Limited | Managing Director | 07 Feb 2023 | 3 Years 9 Months | Current |
| Mounika Pammi Also directs: Ratiorise Capital Advisory LLP, Anmol East Projects LLP, Midland Polymers Limited and 5 more | Director | 20 Jun 2025 | 1 Years 4 Months | Current |
| Suman Mallu Also directs: VSR Paper and Packaging Limited | Director | 01 Sep 2023 | 3 Years 2 Months | Current |
Auditor
Bandaram Pharma Packtech Limited is audited by M M REDDY & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M M REDDY & CO | FY 2023 | 010371S |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 62.70%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 37.30%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 62.70% | 62.70% | 62.60% | 75.00% |
| Public | 37.30% | 37.30% | 37.40% | 25.00% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 1992 | 90304641 | State Bank of India; | ₹25 Lakh | Open | |
| 30 May 1992 | 90307340 | State Bank of India; | ₹25 Lakh | Open | |
| 18 Jan 2024 | 100856382 | Others | ₹10 Cr | Satisfied | |
| 16 Jun 1998 | 90305176 | State Bank of India; | ₹7 Cr | Satisfied | |
| 30 Apr 1996 | 90307610 | Union Bank of India | ₹1.42 Cr | Satisfied |
To see the full charge records of Bandaram Pharma Packtech Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Bandaram Pharma Packtech Limited has 1 deal on record (1 acquisition); the latest was in March 2016.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Acquisition | ₹2.26 Cr | Buyer: Grey Mat Techno Solutions Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bandaram Pharma Packtech Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jabalpur, Madhya Pradesh | Court case (MJC SUC) | Filed against the company | Pending |
To see the full case history of Bandaram Pharma Packtech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bandaram Pharma Packtech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bandaram Pharma Packtech has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACS0289E1ZD | Karnataka | Active | 14 Sep 2022 |
To see the full GST registrations and return filing status of Bandaram Pharma Packtech Limited, buy the company report.
Recent activity
Bandaram Pharma Packtech Limited has 52 board changes on record since 2005: 32 appointments and 20 cessations. The latest: Eswar Reddy Putturu was appointed as Director on 30 Jan 2026.
54 earlier events are in the company report.
Frequently asked questions
Bandaram Pharma Packtech is an active public limited company based in Bangalore, Karnataka, India. The company works in paper and packaging products, within the manufacturing industry. It was incorporated on 05 August 1993 (33+ years old) and is registered under CIN L93090KA1993PLC159827. Listed on BSE: 524602.
Bandaram Pharma Packtech reported revenue of ₹62.92 Cr for FY 2025-26 (up 70.2% YoY) based on consolidated financials.
Bandaram Pharma Packtech has 7 current directors:
- Deepak Bandaram - Managing Director
- Bhandaram Sathyavathi - Director
- Bhandaram Premsai Reddy - Director
- Suryaprakasa Rao Bommisetti - Director
- Mounika Pammi - Director
- Suman Mallu - Director
- Eswar Reddy Putturu - Director
The latest financial statements of Bandaram Pharma Packtech on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bandaram Pharma Packtech is 29AAACS0289E1ZD, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Bandaram Pharma Packtech is L93090KA1993PLC159827. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Bandaram Pharma Packtech is a listed company as per MCA records. Its shares are listed on BSE (code: 524602).
Bandaram Pharma Packtech has 1 court case on record: 1 filed against it. 1 is pending.
Bandaram Pharma Packtech was incorporated on 05 August 1993, making it 33+ years old. It is registered with the Registrar of Companies, Bangalore.
Bandaram Pharma Packtech has 1 deal on record (1 acquisition); the latest was in March 2016.

